Filippseyjar - enska - FDA (Food And Drug Administration)

sahar international trading, inc.; distributor: sahar international trading, inc. - phospholipids , multivitamins - softgel capsule - each softgel capsule contains: 3 sn phosphatidylcholine (phospholipids) 300 mg rrr-alpha-tocopheryl acetate (vitamin e) 6 mg thiamine mononitrate (vitamin b1) 6 mg riboflavin (vitamin b2) 6 mg nicotinamide (vitamin b3) 30 mg pyridoxine hydrochloride (vitamin b6) 6 mg cyanocobalamin (vitamin b12) 6 mg

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - nintedanib esilate, quantity: 180.6 mg (equivalent: nintedanib, qty 150 mg) - capsule, soft - excipient ingredients: iron oxide red; titanium dioxide; hard fat; lecithin; gelatin; glycerol; iron oxide yellow; medium chain triglycerides; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - ofev is indicated in combination with docetaxel for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (nsclc) of adenocarcinoma tumour histology after failure of first line chemotherapy.,ofev is indicated for the treatment of idiopathic pulmonary fibrosis (ipf).,ofev is also indicated for the treatment of other chronic fibrosing interstitial lung diseases (ilds) with a progressive phenotype.,ofev is indicated for slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (ssc-ild).

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - nintedanib esilate, quantity: 120.4 mg (equivalent: nintedanib, qty 100 mg) - capsule, soft - excipient ingredients: hard fat; lecithin; glycerol; iron oxide red; gelatin; medium chain triglycerides; titanium dioxide; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - ofev is indicated in combination with docetaxel for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (nsclc) of adenocarcinoma tumour histology after failure of first line chemotherapy.,ofev is indicated for the treatment of idiopathic pulmonary fibrosis (ipf).,ofev is also indicated for the treatment of other chronic fibrosing interstitial lung diseases (ilds) with a progressive phenotype.,ofev is indicated for slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (ssc-ild).

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

astellas pharma australia pty ltd - enzalutamide, quantity: 40 mg - capsule, soft - excipient ingredients: gelatin; purified water; caprylocaproyl macrogolglycerides; butylated hydroxyanisole; butylated hydroxytoluene; titanium dioxide; sorbitol; glycerol; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; iron oxide black; macrogol 400; polyvinyl acetate phthalate - xtandi is indicated for:,? the treatment of patients with metastatic hormone-sensitive prostate cancer.,? the treatment of patients with non-metastatic castration-resistant prostate cancer (see prosper, section 5.1 clinical trials).,? the treatment of patients with metastatic castration resistant prostate cancer following failure of androgen deprivation therapy in whom chemotherapy is not yet indicated.,? the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.

Bandaríkin - enska - NLM (National Library of Medicine)

dn company co., ltd. - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - dimethicone 1.5 g in 150 ml - purpose: skin protectant indications & usage: this cleansing emulsion contains h2 (hydrogen water), where the water particles help remove gently make-up and all impurities leaving the skin soft and moisture .

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - omega-3-acid ethyl esters 90, quantity: 1000 mg - capsule, soft - excipient ingredients: purified water; gelatin; glycerol; d-alpha-tocopherol - hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response. treatment is indicated for the following types of dyslipidaemia (fredrickson classification) only: -type iv & v as monotherapy and with close monitoring of ldl-c levels. - type iib as add-on therapy to statins, when control of triglycerides with statins has been shown to be insufficient. patients with higher baseline levels of triglycerides are more likely to exhibit a better response to omacor. omacor is not indicated in exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). there are insufficient data to support the use in patients with secondary endogenous hypertriglyceridaemia including patients with diabetes mellitus.

Írland - enska - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - alanine; arginine ; aspartic acid; cysteine; glutamic acid ; glycine; histidine; isoleucine; leucine ; lysine; methionine; ornithine hydrochloride; phenylalanine; proline; serine; taurine; threonine; tryptophan; tyrosine; valine; potassium acetate; calcium chloride dihydrate; magnesium acetate tetrahydrate; sodium glycerophosphate, hydrated; glucose; refined olive oil + refined soybean oil - emulsion for infusion - - - solutions for parenteral nutrition; combinations

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - dutasteride, quantity: 500 microgram - capsule, soft - excipient ingredients: titanium dioxide; mono- and di- glycerides; lecithin; iron oxide yellow; butylated hydroxytoluene; medium chain triglycerides; gelatin; glycerol - avodart is indicated for use as monotherapy for the management of symptomatic benign prostatic hyperplasia (bph) or as combination therapy with an alpha blocker which is approved for use in bph and which has been dose titrated in accordance with the relevant recommendations in the product information for that alpha blocker.

Írland - enska - HPRA (Health Products Regulatory Authority)

patheon softgels b.v. - ibuprofen - chewable capsule, soft - 100 milligram(s) - ibuprofen

Malta - enska - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - dutasteride - soft capsule - dutasteride 0.5 mg - urologicals